Search Results - Giuseppe Privitera
- Showing 1 - 19 results of 19
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles by Giuseppe Barbagallo, Sabrina Paratore, Rosario Caltabiano, Stefano Palmucci, Héctor Soto Parrà, Giuseppe Privitera, Fábio Motta, Salvatore Lanzafame, G Scaglione, Antonio Longo, Vincenzo Albanese, Francesco Certo
Published 2014Artigo -
9
Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy by Pietro Valerio Foti, Giuseppe Privitera, Sebastiano Piana, Stefano Palmucci, Corrado Spatola, Roberta Bevilacqua, L. Raffaele, Vincenzo Salamone, Rosario Caltabiano, Gaetano Magro, Giovanni Li Destri, Pietro Milone, Giovanni Carlo Ettorre
Published 2016Artigo -
10
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications by Franco Scaldaferri, Gianluca Ianiro, Giuseppe Privitera, Loris Riccardo Lopetuso, Lorenzo Maria Vetrone, Valentina Petito, Daniela Pugliese, Matteo Neri, Giovanni Cammarota, Yehuda Ringel, Guido Costamagna, Antonio Gasbarrini, Ivo Boškoski, Alessandro Armuzzi
Published 2020Revisão -
11
A 62-MeV proton beam for the treatment of ocular melanoma at Laboratori Nazionali del Sud-INFN by G.A.P. Cirrone, G. Cuttone, P. Lojacono, Salvatore Nigro, V. Mongelli, I.V. Patti, Giuseppe Privitera, L. Raffaele, D. Rifuggiato, M.G. Sabini, Vincenzo Salamone, Corrado Spatola, L.M. Valastro
Published 2004Artigo -
12
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease by Luisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, Lorenzo Bertani, Francesco Costa, Giuseppe Privitera, Barbara Tolusso, Clara Di Mario, Eleonora Albano, Gherardo Tapete, Elisa Gremese, Alfredo Papa, Antonio Gasbarrini, Gian Ludovico Rapaccini, Alessandro Armuzzi
Published 2019Artigo -
13
Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease by Giuseppe Privitera, S. Onali, Daniela Pugliese, Sara Renna, Edoardo Savarino, Anna Viola, Davide Giuseppe Ribaldone, Andrea Buda, Cristina Bezzio, Gionata Fiorino, Massimo Claudio Fantini, Franco Scaldaferri, Luisa Guidi, Silvio Danese, Antonio Gasbarrini, Ambrogio Orlando, Alessandro Armuzzi
Published 2020Artigo -
14
ACTA OTORHINOLARYNGOLOGICA ITALICA by Martino Ruggieri, Andrea D. Praticò, Agostino Serra, Luigi Maiolino, Salvatore Cocuzza, Paola Di Mauro, Luisa Licciardello, Pietro Milone, Giuseppe Privitera, Giuseppe Belfiore, Massimo Di Pietro, Francesco Di Raimondo, Alessandra Romano, Annalisa Chiarenza, M. Muglia, Agata Polizzi, D. Gareth Evans
Published 2016Revisão -
15
Impact of COVID‐19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high‐volume Italian inflammat... by Franco Scaldaferri, Daniela Pugliese, Giuseppe Privitera, S. Onali, Loris Riccardo Lopetuso, Gianenrico Rizzatti, Carlo Romano Settanni, Marco Pizzoferrato, Elisa Schiavoni, Laura Turchini, Valeria Amatucci, Daniele Napolitano, T Bernabei, Vincenzina Mora, Lucrezia Laterza, Alfredo Papa, Luisa Guidi, Gian Lodovico Rapaccini, Antonio Gasbarrini, Alessandro Armuzzi
Published 2020Artigo -
16
Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment by Marco Ragusa, Alessandra Majorana, Luisa Statello, Marco Maugeri, Loredana Salito, Davide Barbagallo, Maria Rosa Guglielmino, Laura R. Duro, Rosario Angelica, Rosario Caltabiano, Antonio Biondi, Maria Di Vita, Giuseppe Privitera, Marina Scalia, Alessandro Cappellani, Enrico Vasquez, Salvatore Lanzafame, Francesco Basile, Cinzia Di Pietro, Michele Purrello
Published 2010Artigo -
17
GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis by Nitish Rana, Giuseppe Privitera, Hannah Kondolf, Katarzyna Bulek, Susana Lechuga, Carlo De Salvo, Daniele Corridoni, Agne Antanaviciute, Rebecca L. Maywald, Alexander M. Hurtado, Junjie Zhao, Emina H. Huang, Xiaoxia Li, E. Ricky Chan, Alison Simmons, Giorgos Bamias, Derek W. Abbott, Jason D. Heaney, Andrei I. Ivanov, Theresa T. Pizarro
Published 2022Artigo -
18
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the <scp>IG‐IBD LIVE</scp> study by Daniela Pugliese, Giuseppe Privitera, Federica Crispino, Nicolò Mezzina, Fabiana Castiglione, Gionata Fiorino, Lucrezia Laterza, Anna Viola, Lorenzo Bertani, Flavio Caprioli, Maria Cappello, Brigida Barberio, Chiara Ricci, Paola Balestrieri, Marco Daperno, Dario Pluchino, Fernando Rizzello, Maria Lia Scribano, Renato Sablich, Luca Pastorelli, Francesco Manguso, Angela Variola, A. Di Sario, Laurino Grossi, Alessandro Armuzzi
Published 2022Artigo -
19
Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy by Cinzia Di Pietro, Salvatore Piro, Giovanni Tabbı̀, Maria Alessandra Ragusa, Valentina Di Pietro, Vincenzo Zimmitti, Francesco Cuda, M. Anello, Ugo Consoli, Elisa Trovato Salinaro, Massimo Caruso, Carlo Vancheri, Nunzio Crimi, M.G. Sabini, G.A.P. Cirrone, L. Raffaele, Giuseppe Privitera, Alfredo Pulvirenti, Rosalba Giugno, Alfredo Ferro, G. Cuttone, Salvatore Nigro, Roberto Purrello, Francesco Purrello, Michele Purrello
Published 2005Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Biology
Disease
Inflammatory bowel disease
Cancer
Immunology
Intensive care medicine
Pathology
Ulcerative colitis
Biochemistry
Bioinformatics
Cancer research
Cell biology
Gastroenterology
Genetics
Inflammation
Inflammatory Bowel Diseases
Physics
Vedolizumab
Adverse effect
Anatomy
Apoptosis
Chemotherapy
Colorectal cancer
Coronavirus disease 2019 (COVID-19)
Crohn's disease
Drug
Environmental health
Gene